An estimated 1 million people are affected by DVT in the United States each year, and up to 100,000 people die from it. With the advent of new oral anticoagulants (NOACs) and innovative invasive techniques, the field of VTE diagnosis and treatment is ever-evolving. Since the beginning of the COVID-19 pandemic, the incidence of thromboembolism has increased. The incidence of VTE in COVID-19 patients in the ICU … https://speakersnetwork.com/forms/VTEAnticoaulation.pdf